ArticleAmerican journal of translational research2023
Effect of graded cardiac rehabilitation care on clinical efficacy and quality of life in patients with CHD after OPCAB.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Effects of disease severity-based nursing intervention on immune function and IFN-γ, IL-6, and TNF-α for children with IgA vasculitis nephritis.Naunyn-Schmiedeberg's archives of pharmacology · 2025Article
- Effect of graded nursing based on risk early warning concept on the incidence of pressure injury, quality of life, and negative affect of long-term bedridden patients.American journal of translational research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo probe the effect of graded cardiac rehabilitation care on clinical efficacy and quality of life in patients with severe coronary heart disease (CHD) after treatment with off-pump coronary artery bypass (OPCAB).
methodsData of 100 patients with severe CHD treated by OPCAB from February 2020 to August 2021 in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology were retrospectively collected. Based on the nursing methods, 52 patients who receiving graded cardiac rehabilitation care were divided to an observation group, and 48 patients receiving conventional cardiac rehabilitation care were divided to a control group. Clinical efficacy, cardiac and pulmonary functions, exercise endurance, quality of life, and adverse cardiovascular events were assessed after 6 months of rehabilitation. According to the prognosis, the patients were divided into a poor prognosis group and a good prognosis group. The risk factors of adverse cardiovascular events affecting the prognosis of the patients were analyzed by logistic regression.
resultsThe total effective rate of rehabilitation in the observation group was higher than that in the control group (80.77% vs. 58.33%, P<0.05). After 6 months of rehabilitation, the improvement of cardiac function and pulmonary function in the observation group was better than that in the control group (P<0.05). In addition, the exercise endurance, quality of life and health status in the observation group were better than those in the control group (P<0.05). After six months of follow-up, it was found that the incidence of adverse cardiovascular events in the observation group was lower than that in the control group (P<0.05). Unconditional classification logistic regression analysis showed that diabetes, left ventricular ejection fraction (%) ≤50, left main artery disease, and type C disease are risk factors for adverse cardiovascular events after OPCAB in patients with severe CHD (P<0.05).
conclusionAfter OPCAB treatment for severe CHD, graded cardiac rehabilitation care can improve nursing efficacy, promote the recovery of cardiopulmonary function, improve exercise endurance, quality of life and health status, and reduce the incidence of adverse cardiovascular events in patients. Diabetes, left ventricular ejection fraction, left main artery disease, and type C disease were independent risk factors for adverse cardiovascular events.
Indexed as
Identifiers
37056845PMC10086870W4365479464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.